Amy Siu

Amy Siu, M.S., Director, Remix Therapeutics Amy Siu is currently Head of DMPK at Remix Therapeutics in Watertown, MA, where she oversees discovery and development DMPK workflows and is responsible for Clinical Pharmacology strategy. Her therapeutic expertise spans oncology, CNS, tropical diseases, and age-related conditions. Previously, she spent approximately three years at AbbVie as a DMPK project representative and six years at Eisai, where she led the Drug Metabolism group. She has served as co-chair of the SLAS ADMET Special Interest Group for the past 9 years. Her research interests include CYP induction, and she has participated in the IQ Working Group on Drug Metabolizing Enzyme Induction.